Table 5.
Variable | nb | Parameter estimate | p |
---|---|---|---|
CYP2A6 normal allelesc | 88 | −0.009 ± 0.003 | 0.003 |
CYP2A6*1A | 16 | −0.007 ± 0.003 | 0.02 |
CYP2A6*9 | 6 | −0.007 ± 0.004 | 0.09 |
UGT2B10*2 (67Y) | 11 | −0.007 ± 0.002 | 0.0007 |
UGT2B10*3 (481D) | 2 | 0.012 ± 0.005 | 0.02 |
Total adjusted R2 | 0.37 |
Results of linear regression analyses treating CYP2A6 null alleles (CYP2A6*2, *4, *12 and *38) and UGT2B10*1 as the reference. Genetic variables are coded as number of haplotypes per subject (0,1,2). Negative parameter estimates indicate reduced nicotine glucuronidation relative to the reference genotype.
Non-deuterated (D0)-(nicotine-glucuronide / (nicotine-glucuronide + nicotine + cotinine + cotinine-glucuronide + trans-3′-hydroxycotinine))
number of alleles
all CYP2A6 alleles excluding CYP2A6*1A, *9 and assumed null alleles CYP2A6*2, *4, *12 and *38.